Literature DB >> 3155863

Identification of a single chromosome in the normal human genome essential for suppression of hamster cell transformation.

A Stoler, N Bouck.   

Abstract

Normal human fibroblasts were fused to carcinogen-transformed baby hamster kidney (BHK) cells and found to be able to suppress the anchorage-independent transformed phenotype of the hamster cells. This suppression was not due to interspecies incompatibility, for transformation could be effectively expressed in hybrids if either the human or the BHK parent had initially been transformed by a dominantly acting viral genome. Upon growth of suppressed hybrids, loss of human chromosomes was accompanied by the re-expression of transformation. Karyotype analysis indicated that only human chromosome 1 was retained in all hybrids that were suppressed and was lost in all hybrids in which transformation was re-expressed. Cytological evidence for the presence or absence of chromosome 1 was confirmed by electrophoretic identification of the human isozyme for phosphoglucomutase 1. Clones re-expressing transformation were isolated from two suppressed hybrids and in both cases loss of suppression was accompanied by the loss of human chromosome 1. Thus, the maintenance of suppression in these cross-species hybrids appears to require the continued presence of normal human chromosome 1. These findings raise the possibility that the frequent involvement of human chromosome 1 in potentially inactivating aberrations in human tumors may reflect a suppressor role for this chromosome in human malignancy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3155863      PMCID: PMC397082          DOI: 10.1073/pnas.82.2.570

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Genetic control of tumorigenicity in interspecific mammalian cell hybrids.

Authors:  R Kucherlapati; S I Shin
Journal:  Cell       Date:  1979-03       Impact factor: 41.582

2.  Suppression of tumorigenicity in somatic cell hybrids. I. Suppression and reexpression of tumorigenicity in diploid human X D98AH2 hybrids and independent segregation of tumorigenicity from other cell phenotypes.

Authors:  H P Klinger
Journal:  Cytogenet Cell Genet       Date:  1980

3.  Evaluation of chemical carcinogenicity by in vitro neoplastic transformation.

Authors:  N Bouck; G Di Mayorca
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

4.  Quantitative analysis of high-resolution trypsin-giemsa bands on human prometaphase chromosomes.

Authors:  U Francke; N Oliver
Journal:  Hum Genet       Date:  1978-12-18       Impact factor: 4.132

5.  Human cell hybrids: analysis of transformation and tumorigenicity.

Authors:  E J Stanbridge; C J Der; C J Doersen; R Y Nishimi; D M Peehl; B E Weissman; J E Wilkinson
Journal:  Science       Date:  1982-01-15       Impact factor: 47.728

6.  Cytogenetic features of human neuroblastomas and cell lines.

Authors:  G M Brodeur; A A Green; F A Hayes; K J Williams; D L Williams; A A Tsiatis
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

7.  A general theory of carcinogenesis.

Authors:  D E Comings
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

8.  Chromosome 1 abnormalities in relapse and terminal stages in childhood leukemia.

Authors:  H Morse; T Hays; B Rose; A Robinson
Journal:  Med Pediatr Oncol       Date:  1979

9.  Break points in chromosome #1 abnormalities of 218 human neoplasms.

Authors:  V Brito-Babapulle; N B Atkin
Journal:  Cancer Genet Cytogenet       Date:  1981-11

10.  Decreased tumorigenicity of rodent cells after fusion with leukocytes from normal and leukemic donors.

Authors:  A H Geurts van Kessel; W C den Boer; A J van Agthoven; A Hagemeijer
Journal:  Somatic Cell Genet       Date:  1981-11
View more
  19 in total

Review 1.  Suppression of the neoplastic phenotype and "anti-oncogenes".

Authors:  R Schäfer
Journal:  Blut       Date:  1987-05

2.  Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression.

Authors:  N C Dracopoli; P Harnett; S J Bale; B Z Stanger; M A Tucker; D E Housman; R F Kefford
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

3.  A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.

Authors:  D J Good; P J Polverini; F Rastinejad; M M Le Beau; R S Lemons; W A Frazier; N P Bouck
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  Low-frequency loss of heterozygosity in Moloney murine leukemia virus-induced tumors in BRAKF1/J mice.

Authors:  J K Lander; H Fan
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

5.  Tumor suppression involves down-regulation of interleukin 3 expression in hybrids between autocrine mastocytoma and interleukin 3-dependent parental mast cells.

Authors:  I D Diamantis; A P Nair; H H Hirsch; C Moroni
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

6.  Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis.

Authors:  B A Mock; M M Krall; J K Dosik
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

7.  Loss of heterozygosity in hypotriploid cell cultures from testicular tumours.

Authors:  J M Parrington; L F West; S Povey
Journal:  Hum Genet       Date:  1987-11       Impact factor: 4.132

8.  The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor.

Authors:  Susanne Schlisio; Rajappa S Kenchappa; Liesbeth C W Vredeveld; Rani E George; Rodney Stewart; Heidi Greulich; Kristina Shahriari; Nguyen V Nguyen; Pascal Pigny; Patricia L Dahia; Scott L Pomeroy; John M Maris; A Thomas Look; Matthew Meyerson; Daniel S Peeper; Bruce D Carter; William G Kaelin
Journal:  Genes Dev       Date:  2008-03-11       Impact factor: 11.361

9.  Loss of thrombospondin transcriptional activity in nickel-transformed cells.

Authors:  K Salnikow; S Cosentino; C Klein; M Costa
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

Review 10.  Neuronal apoptosis by prolyl hydroxylation: implication in nervous system tumours and the Warburg conundrum.

Authors:  Susanne Schlisio
Journal:  J Cell Mol Med       Date:  2009-08-19       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.